SitemapImpressumdeutschenglish
MHH Logo

Prof. Dr. Thomas Illig

 


  Prof. Dr. Thomas Illig
  Scientific Head and CEO

  Phone: +49 (511) 532 - 8674 (Secretary)
  Email: Illig.Thomasmh-hannover.de

 

 

 

 

Background


Since January first Prof. Thomas Illig is heading the Hannover Unified Biobank, including all biomaterials from Hannover Medical School (MHH). Prof. Illig is establishing a modern, unified high-throughput biobanking centre in a new building (Clinical Research Center = CRC) being finished mid of 2013. The last 15 years he worked at Helmholtz Zentrum Muenchen (HMGU) at the end as director of the Independent Research Unit of Molecular Epidemiology. He has a longstanding experience in environmental, molecular and genetic epidemiology. He co-organized large population based and disease related epidemiological studies (e.g. KORA, Augsburg Diabetes Family Study). One main focus is the molecular analysis of cardiovascular and metabolic diseases mainly of type 2 diabetes and CVD but also on other complex diseases like asthma, atopic eczema and lung cancer. Prof. Illig pioneered work on the combination of different systematic molecular data eg. the combination of genome wide association (GWAs) and metabolomics, transcriptomics or epigenomics, leading to better understanding of complex diseases. Thomas Illig established the Genome Analysis Center (GAC) of HMGU and was one of the four founding members of the metabolomics platform MetaP of the Helmholtz Zentrum München. Prof. Illig is member in several international genetics consortia, many of them focussing on cardio-metabolic diseases (DIAGRAM ands MAGIC for type 2 diabetes; IBC 50K CAD consortium, Global BPgen Consortium, CARDIoGRAM Consortium for cardiovascular diseases). In Munich Thomas Illig was head of the biobank of the department of epidemiology with more than 50 000 genomic DNA samples consisting of population-based and case-specific cohorts. Prof. Illig is leading the biobank group of the German National Cohort including 200 000 participants.

Prof. Illig has organized the MBA programme “Genetic and Molecular Epidemiology” at LMU Pettenkofer School of Public Health. In the last 5 years he authored or co-authored more than 300 peer-reviewed publications also in leading journals such as Science, Nature, Nature Genetics, Plos Genetics, Lancet and the American Journal of Human Genetics.

Education

  • 2010 Adjunct professor at Ludwig Maximilians-University Munich
  • 2006 Postdoctoral lecture qualification (“Habilitation”) and conferral of associate professorship (“Priv.-Doz.”) at the Ludwig-Maximilians-University München, „Concepts of genomic association studies to decipher complex diseases“
  • 1995 Doctor in biology by thesis „O-Glycosilation in Saccharomyces cerevisae“, Department of Cell Biology, University of Regensburg
  • 1992 - 1995 PhD in Cell Biology, O-Glycosilation in yeast, University of Regensburg
  • 1986 - 1991 Study of biology, University of Regensburg

Professional Experience

  • Since 01/2012 CEO and scientific head of Hannover Unified Biobank (HUB), Hannover Medical School
  • 01/2011 - 12/2011 Head of Research Unit of Molecular Epidemiology, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health, Neuherberg,
  • Since 2009 Head of Biomaterials group of the German National Cohort (200 000 participants)
  • 2001 - 2010 Group leader of working group “Epidemiology-Biobanking-Genomics” in the Institute of Epidemiology Helmholtz Zentrum Muenchen, German Research Center for Environmental Health, Neuherberg,
  • 1998 - 2001 PostDoc, Institute of Epidemiology, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health, Neuherberg
  • 1996 - 1998 PostDoc, Institute of Mammalian Genetics, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health, Neuherberg
  • 1995 - 1996 PostDoc, Department of Cell Biology, University of Regensburg Teaching experience
  • Since 2001 Organisation of the MBA programme „Molecular and genetic epidemiology“ at Ludwig-Maximilians-University München, Pettenkofer School of Public Health, Different lectures in this programme
  • Since 2003 Molecular Epidemiology at the University of Mainz
  • 2005 - 2009 Molecular Epidemiology at the Technical University of Munich

Awards

  • 2010 “Paula and Richard von Hertwig” price for interdisciplinary work at Helmholtz Zentrum München
  • 2006 Herbert-Herxheimer-Förderpreis of the German Society for Allergy and Clinical Immunology (DGAKI)
  • 2005 “Paula and Richard von Hertwig” price for interdisciplinary work at Helmholtz Zentrum München

Reviewer (selected journals)

  • Nature Genetics, American Journal of Human Genetics, Circulation, PLOS Genetics,
  • Experimental Dermatology, Allergy, Clinical and Experimental Allergy, Journal of Investigative Dermatology,
  • Journal of Allergy and Clinical Immunology, Human Molecular Genetics, Diabetologia,
  • Diabetes, Molecular Gerontology, International Journal of Obesity,
  • Molecular Nutrition and Food Research, PLOS Biology

Grant Reviewer

  • European Union
  • Netherland Research Foundation
  • University of Verona
  • German Research Community (DFG)
  • University of Vienna

Membership in national and international consortia

  • IL6R Genetics Consortium Emerging Risk Factors Collaboration
  • MTHFR Studies Collaborative Group
  • DIAGRAM Consortium
  • CARDIoGRAM Consortium
  • Cardiogenics Consortium
  • MONICA/KORA Investigators
  • KORA Study Group
  • Cooperative Health Research in the Region of Augsburg (KORA) Study Group
  • Global BPgen Consortium, Diabetes Genetics Replication and Meta-analyses (DIAGRAM+) Study
  • International Consortium for Blood Pressure (ICBP-GWAS)
  • Meta-analyses of Glucose and Insulin-Related Traits Consortium (MAGIC)
  • IBC 50K CAD Consortium, MAGIC Investigators
  • International Parkinson's Disease Genomics Consortium (IPDGC)
  • Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors
  • Collaboration, ENGAGE Consortium
  • AIRGENE Study Group, Coronary Artery Disease Consortiumm